Skip to main content

J&J and BHC Reach Deal On Body Powder Litigation

J&J and BHC Reach Deal On Body Powder Litigation

J&J and BHC Reach Deal On Body Powder Litigation

Introduction

In a U.S. Securities and Exchange Commission filing, Bausch Health Companies Inc. (BHC) struck a deal with Johnson & Johnson to cover the costs of litigation involved in personal injury and product liability lawsuits linked to Shower to Shower product that Bausch acquired in 2012.

The deal covers suits filed before March 2020. J&J will compensate Bausch for any regulatory actions related to the production, use or sale of the talcum powder up to September 2012. The lawsuits against Bausch included several filed into the multidistrict litigation involving J&J's talcum products in New Jersey federal court and state courts. Some of the cases claimed that Shower to Shower powder cause ovarian cancer to women who used them for personal hygiene purposes. The company stated in the annual report that it was actively defending itself in suits that have not been dismissed yet.

J&J faces more than 14,000 claims linked to asbestos exposure from its talc-based products causing ovarian cancer or mesothelioma.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

Appeals Court Upholds $611M Roundup Verdict

Categories: Roundup

A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.

The case involved three plaintiffs from New…

Valsartan “Wave 2” Bellwether Trial Schedule Set by Court

Categories: Valsartan

As the first Valsartan bellwether trial approaches in September 2025, the federal judge overseeing the multidistrict litigation (MDL) is preparing a second set of trials.

This move comes in anticipation of the possibility that parties may…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!